Trial of Combination of Ixazomib and Lenalidomide and Dexamethasone in Smoldering Multiple Myeloma

NCT02916771 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Smoldering Multiple Myeloma

Interventions

DRUG: Ixazomib
DRUG: Lenalidomide
DRUG: Dexamethasone

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]